Literature DB >> 8028607

Deletion screening of mitochondrial DNA via multiprimer DNA amplification.

B P Ernst1, E Wilichowski, M Wagner, F Hanefeld.   

Abstract

We report an application of multiprimed polymerase chain reaction (PCR) which allows a rapid, nonradioactive detection of deletions in mitochondrial DNA using EDTA-blood and muscle samples. The use of two primer sets consisting of three forward and five reverse primers, respectively, allows a competitive PCR resulting in significant amplification products only in the presence of deletion-harbouring DNA species. Under the conditions described, deletions causing Kearns-Sayre syndrome (KSS) and progressive external ophthalmoplegia (PEO) have been successfully detected. The location of the primers on mitochondrial DNA used in this study should allow identification and localization of most of the large-scale deletions (i.e. more than 1 kb) of mitochondrial DNA reported so far.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8028607     DOI: 10.1006/mcpr.1994.1006

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  3 in total

1.  S1 nuclease hybrid analysis of mitochondrial DNA amplified by long-distance PCR: rapid screening for small-scale rearrangements.

Authors:  K Lundin; E Wilichowski; B P Ernst; F Hanefeld
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

2.  Changes in mitochondrial DNA and its encoded products in alcoholic cirrhosis.

Authors:  Chun Tang; Xianchun Liang; Hongming Liu; Liping Guo; Ruxian Pi; Juntao Yang
Journal:  Int J Clin Exp Med       Date:  2012-06-15

3.  De novo double mutation in PAX6 and mtDNA tRNA(Lys) associated with atypical aniridia and mitochondrial disease.

Authors:  Anja Brinckmann; Klaus Rüther; Kathleen Williamson; Birgit Lorenz; Barbara Lucke; Peter Nürnberg; Frans Trijbels; Antoon Janssen; Markus Schuelke
Journal:  J Mol Med (Berl)       Date:  2006-10-10       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.